Ra Medical Systems (NYSE:RMED) announced today that it appointed Brian D. Conn as its interim chief financial officer (CFO).
Conn will serve as the company’s principal financial officer and principal accounting officer, effective immediately.
He has served as a consultant to the Carlsbad, California-based developer of the Dabra excimer laser system for treating vascular diseases since May 25, 2022. According to a news release, Conn replaces Will McGuire, who assumed the interim CFO role on July 8, following Andrew Jackson’s departure from the role.
McGuire will continue in his positions as CEO and director of the company, Ra Medical said.
“We are fortunate to have a professional with Brian’s extensive and highly relevant experience step into our senior financial position as our board of directors continues to assess strategic alternatives with the goal of maximizing value for Ra Medical’s stockholders,” McGuire said in the release.
Conn has served in senior-level financial positions at public and private companies for more than 25 years, the company said, having held the CFO role at a number of medical device companies. He was previously CFO at Quantapore Inc., Imagion Biosystems and Verdezyne.